Omada Health (NASDAQ:OMDA) President Sells $79,114.36 in Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 4,589 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $17.24, for a total value of $79,114.36. Following the completion of the transaction, the president owned 316,238 shares of the company’s stock, valued at $5,451,943.12. This trade represents a 1.43% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Wei-Li Shao also recently made the following trade(s):

• On Wednesday, April 8th, Wei-Li Shao sold 2,829 shares of Omada Health stock. The shares were sold at an average price of $12.71, for a total value of $35,956.59.

Omada Health Stock Performance

NASDAQ:OMDA traded down $0.24 during trading on Tuesday, reaching $17.09. The company’s stock had a trading volume of 729,778 shares, compared to its average volume of 1,213,043. The firm has a market cap of $1.02 billion and a price-to-earnings ratio of -63.30. The firm has a 50 day moving average of $15.45 and a 200-day moving average of $14.80. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The firm had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. Equities research analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on OMDA. Barclays upped their price objective on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Citigroup restated an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. Evercore reiterated an “outperform” rating and set a $20.00 price target on shares of Omada Health in a research note on Friday, May 8th. Finally, Canaccord Genuity Group set a $24.00 price target on Omada Health in a research note on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Raymond James Financial Inc. bought a new position in shares of Omada Health during the 2nd quarter worth $32,000. Quarry LP bought a new position in shares of Omada Health during the 4th quarter worth $29,000. TD Waterhouse Canada Inc. bought a new position in shares of Omada Health during the 4th quarter worth $32,000. Inlight Wealth Management LLC bought a new position in shares of Omada Health during the 4th quarter worth $45,000. Finally, JPMorgan Chase & Co. bought a new position in shares of Omada Health during the 3rd quarter worth $82,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.